Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia
Background Micro-RNAs (miRNAs) control gene expression by destabilizing targeted transcripts and inhibiting their translation. Aberrant expression of miRNAs has been described in many human cancers, including chronic myeloid leukemia. Current first-line therapy for newly diagnosed chronic myeloid le...
| الحاوية / القاعدة: | Haematologica |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Ferrata Storti Foundation
2010-08-01
|
| الوصول للمادة أونلاين: | https://haematologica.org/article/view/5686 |